Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Femara shows significant survival advantage over tamoxifen in advanced postmenopausal breast cancer

Feb. 25, 2002

INGN-201 registered as Advexin

Feb. 25, 2002

Phase II results for atrasentan in prostate cancer patients reported in Birmingham

Feb. 25, 2002

U.K. investigators evaluate intravesical MeGLA in superficial bladder cancer patients

Feb. 25, 2002

ZD-0473 associated with manageable toxicity, activity in hormone-refractory prostate cancer

Feb. 25, 2002

Researchers at the University of Edinburgh synthesize anticancer ruthenium complexes

Feb. 22, 2002

Compounds for damaging newly formed vascular endothelium disclosed by Angiogene

Feb. 22, 2002

Zevalin therapeutic regimen approved for NHL

Feb. 22, 2002

First multiple-dose clinical study of ERA-923 in healthy postmenopausal women

Feb. 22, 2002

Inhibitors of cyclin-dependent kinases with potential as antitumor agents

Feb. 21, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 10, 2026.
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
Korsana boosts Alzheimer’s work with reverse merger, $380M financing
BioWorld Science
Just over a month after emerging from stealth and disclosing a $150 million series A, Korsana Biosciences Inc. is making the leap to the public market via a...
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld
Hematopoietic stem cell research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...